October 2, 2024 01:39 PM EDT
FDA+

EMA looks to make its drug ap­proval process­es more ef­fi­cient

Zachary Brennan

Senior Editor

The Eu­ro­pean Med­i­cines Agency is look­ing to speed up its drug re­view time­lines, fol­low­ing a re­cent re­port show­ing how ap­pli­ca­tions can see long de­lays. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ex­clu­sive: Af­ter dis­cov­er­ing an­tibi­otics with AI, a 31-year-old first-time CEO rais­es $17M to fight ag­ing

Scoop: Found­ing CEO leaves Atom­wise, cast­ing doubt over a once high-fly­ing AI start­up 

BioN­Tech opens the hood on its AI am­bi­tions, and they're not just for mR­NA

Lil­ly in­vests $4.5B in new In­di­ana site to bring clin­i­cal man­u­fac­tur­ing in-house

J&J and Bay­er to lay off al­most 300 staffers in New Jer­sey

sponsored

3 Tiers for AAV Po­ten­cy As­say De­vel­op­ment Suc­cess

A service from the Financial Times